---
document_datetime: 2024-07-26 09:32:16
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tenofovir-disoproxil-viatris-epar-all-authorised-presentations_en.pdf
document_name: tenofovir-disoproxil-viatris-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9885626
conversion_datetime: 2025-12-21 23:57:59.048865
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name              | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging                     | Pack size                       |
|------------------|------------------------------|------------|-----------------------|---------------------------|-----------------------------------------|---------------------------------|
| EU/1/16/1129/001 | Tenofovir disoproxil Viatris | 245 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE)                           | 30 tablets                      |
| EU/1/16/1129/002 | Tenofovir disoproxil Viatris | 245 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE)                           | 90 (3 x 30) tablets (multipack) |
| EU/1/16/1129/003 | Tenofovir disoproxil Viatris | 245 mg     | Film-coated tablet    | Oral use                  | blister (OPA/Alu/PE/Desiccant/ PE- Alu) | 10 tablets                      |
| EU/1/16/1129/004 | Tenofovir disoproxil Viatris | 245 mg     | Film-coated tablet    | Oral use                  | blister (OPA/Alu/PE/Desiccant/ PE- Alu) | 30 tablets                      |
| EU/1/16/1129/005 | Tenofovir disoproxil Viatris | 245 mg     | Film-coated tablet    | Oral use                  | blister (OPA/Alu/PE/Desiccant/ PE- Alu) | 30 x 1 tablets (unit dose)      |